NASDAQ : NMRA
Neumora Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 0.3672 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 69.00M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 53.16M | 60.09M | 62.54M | 45.48M | 31.12M | 24.55M |
| Research & Development | 153.07M | 176.06M | 200.93M | 142.72M | 91.75M | 55.78M |
| Operating Expenses | 206.23M | 236.16M | 263.46M | 188.19M | 122.87M | 80.32M |
| Operating Income | -206.23M | -236.16M | -263.46M | -188.19M | -122.87M | -80.32M |
| Interest Expense | -6.46M | -3.22M | ||||
| Interest & Investment Income | 5.19M | 8.34M | 19.93M | 16.61M | 4.56M | |
| Other Non Operating Income (Expenses) | -210.00K | -767.00K | -78.00K | -170.00K | 405.00K | 11.00K |
| EBT Excluding Unusual Items | -207.72M | -231.80M | -243.61M | -171.75M | -117.90M | -80.31M |
| Pretax Income | -212.72M | -236.80M | -243.61M | -235.66M | -130.90M | -237.31M |
| Income Tax Expense | 30.00K | 130.00K | 178.00K | 268.00K | ||
| Net Income | -212.75M | -236.93M | -243.79M | -235.93M | -130.90M | -237.31M |
| Net Income to Common | -212.75M | -236.93M | -243.79M | -235.93M | -130.90M | -237.31M |
| Shares Outstanding (Basic) | 173.86M | 163.39M | 159.38M | 65.02M | 27.21M | 21.90M |
| Shares Outstanding (Diluted) | 173.86M | 163.39M | 159.38M | 65.02M | 27.21M | 21.90M |
| EPS (Basic) | -1.22 | -1.45 | -1.53 | -3.63 | -4.81 | -10.84 |
| EPS (Diluted) | -1.22 | -1.45 | -1.53 | -3.63 | -4.81 | -10.84 |
| Free Cash Flow | -180.52M | -206.44M | -183.71M | -167.99M | -128.41M | -76.24M |
| Free Cash Flow Per Share | -1.04 | -1.26 | -1.15 | -2.58 | -4.72 | -3.48 |
| EBITDA | -206.19M | -235.95M | -262.83M | -187.53M | -122.28M | -79.78M |
| D&A For EBITDA | 47.00K | 208.00K | 631.00K | 668.00K | 594.00K | 538.00K |
| EBIT | -206.23M | -236.16M | -263.46M | -188.19M | -122.87M | -80.32M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 116.83M | 182.53M | 142.15M | 374.04M | 240.94M | 409.25M |
| Short-Term Investments | 165.43M | 79.94M | 130.94M | |||
| Cash & Short-Term Investments | 116.83M | 182.53M | 307.58M | 453.98M | 371.88M | 409.25M |
| Other Receivables | 919.00K | 200.00K | ||||
| Receivables | 919.00K | 200.00K | ||||
| Prepaid Expenses | 8.04M | 8.01M | 5.26M | 18.00M | 1.62M | 1.20M |
| Restricted Cash | 1.21M | 50.00K | 125.00K | |||
| Other Current Assets | 6.30M | 13.48M | 4.84M | |||
| Total Current Assets | 124.87M | 190.54M | 314.06M | 478.28M | 387.95M | 415.60M |
| Property, Plant & Equipment | 322.00K | 457.00K | 2.92M | 6.86M | 10.64M | 4.04M |
| Long-Term Investments | 9.85M | 23.51M | ||||
| Long-Term Deferred Charges | 2.90M | 1.83M | ||||
| Other Long-Term Assets | 53.00K | 53.00K | 1.21M | 1.23M | 7.82M | |
| Total Assets | 125.25M | 191.05M | 316.97M | 496.19M | 426.23M | 429.30M |
| Accounts Payable | 4.15M | 3.38M | 3.31M | 337.00K | 7.15M | 1.64M |
| Accrued Expenses | 20.26M | 28.79M | 24.59M | 21.26M | 11.54M | 19.10M |
| Current Portion of Leases | 299.00K | 284.00K | 1.85M | 3.38M | 3.37M | 1.06M |
| Other Current Liabilities | 133.00K | 139.00K | 1.64M | 1.49M | ||
| Total Current Liabilities | 27.78M | 32.45M | 29.89M | 25.11M | 23.70M | 23.28M |
| Long-Term Debt | 52.91M | 54.53M | ||||
| Long-Term Leases | 41.00K | 193.00K | 1.85M | 5.07M | 996.00K | |
| Other Long-Term Liabilities | 22.00K | 155.00K | 628.00K | 386.00K | ||
| Total Liabilities | 80.73M | 87.18M | 29.91M | 27.12M | 29.40M | 24.66M |
| Common Stock | 19.00K | 17.00K | 16.00K | 16.00K | 3.00K | 14.00K |
| Additional Paid-In Capital | 1.33B | 1.29B | 1.23B | 1.17B | 21.43M | 11.37M |
| Retained Earnings | -1.28B | -1.18B | -947.22M | -703.43M | -467.51M | -336.61M |
| Comprehensive Income & Other | 62.00K | -76.00K | -774.00K | |||
| Total Common Equity | 44.52M | 103.87M | 287.06M | 469.08M | -446.85M | -325.22M |
| Shareholders' Equity | 44.52M | 103.87M | 287.06M | 469.08M | 396.84M | 404.64M |
| Total Liabilities & Equity | 125.25M | 191.05M | 316.97M | 496.19M | 426.23M | 429.30M |
| Total Debt | 53.25M | 55.01M | 1.85M | 5.23M | 8.44M | 2.05M |
| Net Cash (Debt) | 63.58M | 127.52M | 305.73M | 458.60M | 386.95M | 407.19M |
| Net Cash Per Share | 0.37 | 0.78 | 1.92 | 7.05 | 14.22 | 18.60 |
| Filing Date Shares Outstanding | 187.90M | 182.04M | 161.98M | 158.89M | 32.61M | 31.98M |
| Total Common Shares Outstanding | 186.85M | 174.26M | 161.71M | 158.83M | 32.61M | 31.98M |
| Working Capital | 97.10M | 158.09M | 284.17M | 453.17M | 364.26M | 392.32M |
| Book Value Per Share | 0.24 | 0.60 | 1.78 | 2.95 | -13.70 | -10.17 |
| Tangible Book Value | 44.52M | 103.87M | 287.06M | 469.08M | -446.85M | -325.22M |
| Tangible Book Value Per Share | 0.24 | 0.60 | 1.78 | 2.95 | -13.70 | -10.17 |
| Machinery | 227.00K | 3.19M | 3.18M | 2.94M | 2.30M | |
| Construction In Progress | 41.00K | 514.00K | 215.00K | |||
| Leasehold Improvements | 17.00K | 257.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -212.75M | -236.93M | -243.79M | -235.93M | -130.90M | -237.31M |
| Depreciation & Amortization | 47.00K | 208.00K | 631.00K | 668.00K | 594.00K | 538.00K |
| Other Amortization | 1.72M | 1.21M | ||||
| Loss (Gain) From Sale of Assets | 131.00K | 642.00K | ||||
| Asset Writedown & Restructuring Costs | 63.90M | 13.00M | 157.00M | |||
| Loss (Gain) From Sale of Investments | -749.00K | -2.93M | -5.72M | -3.74M | -708.00K | |
| Stock-Based Compensation | 27.98M | 29.88M | 39.99M | 17.24M | 8.30M | 4.27M |
| Other Operating Activities | 267.00K | 1.92M | 3.31M | 3.48M | 1.77M | 1.04M |
| Change in Accounts Payable | 3.50M | 71.00K | 2.87M | -581.00K | -1.25M | -759.00K |
| Change in Other Net Operating Assets | -668.00K | -508.00K | 19.76M | -8.32M | -5.70M | -202.00K |
| Operating Cash Flow | -180.52M | -206.44M | -182.94M | -163.28M | -114.90M | -75.42M |
| Capital Expenditures | -775.00K | -4.71M | -13.51M | -817.00K | ||
| Sale of Property, Plant & Equipment | 205.00K | 218.00K | ||||
| Investment in Securities | 93.83M | 168.30M | -69.78M | 69.09M | -154.50M | |
| Investing Cash Flow | 94.03M | 168.52M | -70.56M | 64.39M | -168.01M | -817.00K |
| Long-Term Debt Issued | 57.16M | |||||
| Net Debt Issued (Repaid) | 38.76M | 57.16M | ||||
| Issuance of Common Stock | 40.48M | 19.93M | 21.60M | 236.23M | 2.66M | 3.47M |
| Repurchase of Common Stock | -491.00K | |||||
| Other Financing Activities | -445.00K | -3.80M | -923.00K | -1.21M | ||
| Financing Cash Flow | 78.80M | 77.09M | 21.60M | 231.94M | 115.74M | 293.51M |
| Net Cash Flow | -7.69M | 39.17M | -231.89M | 133.04M | -167.17M | 217.27M |
| Free Cash Flow | -180.52M | -206.44M | -183.71M | -167.99M | -128.41M | -76.24M |
| Free Cash Flow Per Share | -1.04 | -1.26 | -1.15 | -2.58 | -4.72 | -3.48 |
| Levered Free Cash Flow | -99.42M | -115.71M | -100.70M | -111.24M | -93.02M | -37.08M |
| Unlevered Free Cash Flow | -97.10M | -114.91M | -100.70M | -111.24M | -93.02M | -37.08M |
| Cash Interest Paid | 2.83M | 1.50M | ||||
| Cash Income Tax Paid | 353.00K | 323.00K | 473.00K | |||
| Change in Working Capital | 2.83M | -437.00K | 22.64M | -8.90M | -6.95M | -961.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 93.14M | 304.19M | 1.71B | 2.60B | ||
| Enterprise Value | 29.56M | 152.75M | 1.37B | 2.09B | ||
| Last Close Price | 0.37 | 1.79 | 10.60 | 17.05 | ||
| PB Ratio | 1.54 | 2.93 | 5.97 | 5.55 | ||
| P/TBV Ratio | 1.55 | 2.93 | 5.97 | 5.55 | ||
| Debt / Equity Ratio | 1.20 | 0.53 | 0.01 | 0.01 | 0.02 | 0.01 |
| Net Debt / Equity Ratio | -1.43 | -1.23 | -1.06 | -0.98 | -0.97 | -1.01 |
| Net Debt / EBITDA Ratio | 0.31 | 0.54 | 1.16 | 2.45 | 3.17 | 5.10 |
| Net Debt / FCF Ratio | 0.35 | 0.62 | 1.66 | 2.73 | 3.01 | 5.34 |
| Quick Ratio | 4.21 | 5.62 | 10.29 | 18.08 | 15.73 | 17.59 |
| Current Ratio | 4.50 | 5.87 | 10.51 | 19.05 | 16.37 | 17.85 |
| Return on Equity (ROE) | -187.11% | -121.21% | -64.48% | -54.49% | -32.67% | -80.18% |
| Return on Assets (ROA) | -73.85% | -58.11% | -40.50% | -25.50% | -17.95% | -16.01% |
| Return on Capital Employed (ROCE) | -211.60% | -148.90% | -91.80% | -39.90% | -30.50% | -19.80% |
| Earnings Yield | -246.86% | -77.89% | -14.24% | -9.06% | ||
| FCF Yield | -261.64% | -67.87% | -10.73% | -6.45% | ||
| Buyback Yield / Dilution | -8.03% | -2.52% | -145.12% | -138.99% | -24.25% | -68.46% |